Pharmacology MPhil/Phd/MD

Major code: PXMR/PXPR/PXMD


Overview

The Department of Molecular and Clinical Pharmacology (http://www.liv.ac.uk/pharmacology/) provides excellent opportunities for basic and clinical research on drug safety science, immuno-pharmacology, individualized medicines, nanomedicines and HIV (www.liv.ac.uk/pharmacology). The department has state-of-the-art research facilities and we have funding from sources including MRC, BBSRC, Wellcome Trust, NIHR, Wolfson Foundation and the EU. Our focus is on research that is directed towards understanding disease processes, defining therapeutic strategies for intervention, and the scientific basis of drug safety. The ultimate aim of this research is to translate laboratory findings into the clinic for the benefit of patients, the public and the healthcare system.

The department is among the most highly rated for research in the United Kingdom and hosts the MRC funded Centre for Drug Safety Science and the Wolfson Centre for Personalized Medicine.

Subject Overview

Our research specifically focuses on the following areas:

  • Drug Safety Science - We undertake fundamental clinical and basic research into the causes, characteristics and consequences of adverse drug reactions
  • The Pharmacology of Infectious Disease – We aim to understand the molecular mechanisms underlying the variability in response to HIV, tuberculosis and hepatitis therapy.
  • Nanomedicines – We investigate the application of nanomedicines in infectious disease

We employ the whole range of cutting-edge experimental techniques from mechanistic studies involving cell-lines and gastrointestinal tissues through to patient studies and clinical trials.

Laboratory research is based mainly in the main campus in the Henry Wellcome Laboratory of Molecular & Cellular Gastroenterology. Clinical research and trials are conducted at the NIHR Biomedical Research Centre in Microbial Diseases at the Royal Liverpool University Hospital, and at the Leahurst Veterinary Field Station within the Philip Leverhulme Equine Hospital and Small Animal Teaching Hospital.

Key Facts

The Institute of Translational Medicine comprises six departments:
Biostatistics
Cellular and Molecular Physiology
Molecular and Clinical Pharmacology
Molecular and Clinical Cancer Medicine
Women’s and Children’s Health

The work of the Institute:
Takes place in the laboratory and in the clinic, forming a continuous cycle of scientific discovery and clinical research that’s yielding remarkable advances in healthcare provision.

Our primary aim:
Is to provide the necessary infrastructure, facilities, professional support and environment to foster collaborative research between basic science and clinical science postgraduates.

The Institute draws on:
The established expertise within each Department to foster, develop and enhance translational medicine work streams and projects throughout the Institute as a whole.

Why The Department of Molecular and Clinical Pharmacology?

Excellent Opportunities

The Department (www.liv.ac.uk/pharmacology/) provides excellent opportunities for basic and clinical research on drug safety science, immuno-pharmacology, individualized medicines, nanomedicines and HIV (www.liv.ac.uk/pharmacology).

State of the art research facilities

The department has state-of-the-art research facilities and have funding from sources including MRC, BBSRC, Wellcome Trust, NIHR, Wolfson Foundation and the EU.

Highly rate research

Our focus is on research that is directed towards understanding disease processes, defining therapeutic strategies for intervention, and the scientific basis of drug safety. The ultimate aim of this research is to translate laboratory findings into the clinic for the benefit of patients, the public and the healthcare system. The Department is among the most highly rated for research in the United Kingdom and hosts the MRC funded Centre for Drug Safety Science and the Wolfson Centre for Personalized Medicine.